{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:07:36Z","timestamp":1789880856417,"version":"4.0.1"},"reference-count":208,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Colloid and Interface Science"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.cis.2013.10.014","type":"journal-article","created":{"date-parts":[[2013,10,19]],"date-time":"2013-10-19T01:00:45Z","timestamp":1382144445000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["Advances in nanomedicines for malaria treatment"],"prefix":"10.1016","volume":"201-202","author":[{"given":"N.P.","family":"Aditya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"Vathsala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.R.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.B.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cis.2013.10.014_bb0005","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(05)66420-3","article-title":"Malaria","volume":"365","author":"Greenwood","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cis.2013.10.014_bb0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature03342","article-title":"The global distribution of clinical episodes of Plasmodium falciparum malaria","volume":"434","author":"Snow","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cis.2013.10.014_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(03)00657-1","article-title":"Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy","volume":"3","author":"Korenromp","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb0020","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1172\/JCI119890","article-title":"A primary malarial infection is composed of a very wide range of genetically diverse but related parasites","volume":"101","author":"Druilhe","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cis.2013.10.014_bb0025","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2014challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cis.2013.10.014_bb0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"Pink","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cis.2013.10.014_bb0035","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/AAC.48.4.1222-1228.2004","article-title":"Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice","volume":"48","author":"Mosqueira","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2013.10.014_bb0040","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jama.2010.121","article-title":"Ancestry and pathology in King Tutankhamun's family","volume":"303","author":"Hawass","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cis.2013.10.014_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0035-9203(94)90484-7","article-title":"Diagnosis of Plasmodium falciparum infections in mummies using the rapid manual ParaSight-F test","volume":"88","author":"Miller","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0050","first-page":"7","article-title":"Malaria and ecosystems: from prehistory to posteradication","volume":"36","author":"de Zulueta","year":"1994","journal-title":"Parassitologia"},{"key":"10.1016\/j.cis.2013.10.014_bb0055","first-page":"759","article-title":"Malaria and murder (Joseph Jones, 1878)","volume":"44","author":"Jarcho","year":"1968","journal-title":"Bull N Y Acad Med"},{"key":"10.1016\/j.cis.2013.10.014_bb0060","first-page":"1","article-title":"Some observations on disease in prehistoric North America","volume":"38","author":"Jarcho","year":"1964","journal-title":"Bull Hist Med"},{"key":"10.1016\/j.cis.2013.10.014_bb0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/milmed\/131.suppl_9.961","article-title":"Comments on biology of human malaria","volume":"131","author":"Garnham","year":"1966","journal-title":"Mil Med"},{"key":"10.1016\/j.cis.2013.10.014_bb0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrmicro1474","article-title":"Ensuring quality and access for malaria diagnosis: how can it be achieved?","volume":"4","author":"Bell","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cis.2013.10.014_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/CMR.00035-07","article-title":"Update on rapid diagnostic testing for malaria","volume":"21","author":"Murray","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cis.2013.10.014_bb0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.trstmh.2012.03.011","article-title":"Status of Plasmodium vivax malaria in the Republic of Korea, 2008\u20132009: decrease followed by resurgence","volume":"106","author":"Yeom","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2583.2011.01128.x","article-title":"Induction of antisporozoite antibodies by biting of transgenic Anopheles stephensi delivering malarial antigen via blood feeding","volume":"21","author":"Yamamoto","year":"2012","journal-title":"Insect Mol Biol"},{"key":"10.1016\/j.cis.2013.10.014_bb0090","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.06212-11","article-title":"Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine","volume":"80","author":"Mathias","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.cis.2013.10.014_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12038-008-0052-5","article-title":"Observations on sporozoite detection in naturally infected sibling species of the Anopheles culicifacies complex and variant of Anopheles stephensi in India","volume":"33","author":"Ghosh","year":"2008","journal-title":"J Biosci"},{"key":"10.1016\/j.cis.2013.10.014_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.trstmh.2004.03.009","article-title":"Larvivorous fish in wells target the malaria vector sibling species of the Anopheles culicifacies complex in villages in Karnataka, India","volume":"99","author":"Ghosh","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1475-2875-11-135","article-title":"The anaemia of Plasmodium vivax malaria","volume":"11","author":"Douglas","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.cis.2013.10.014_bb0110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/QCO.0b013e32834c61e3","article-title":"Plasmodium vivax treatments: what are we looking for?","volume":"24","author":"Price","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb0115","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1086\/599041","article-title":"Vivax malaria: a major cause of morbidity in early infancy","volume":"48","author":"Poespoprodjo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb0120","first-page":"259","article-title":"Mechanisms of acquired immunity and epidemiological patterns of antibody responses in malaria in man","volume":"50","author":"McGregor","year":"1974","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.cis.2013.10.014_bb0125","doi-asserted-by":"crossref","first-page":"e22434","DOI":"10.1371\/journal.pone.0022434","article-title":"The spleen CD4+ T cell response to blood-stage Plasmodium chabaudi malaria develops in two phases characterized by different properties","volume":"6","author":"Muxel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2013.10.014_bb0130","doi-asserted-by":"crossref","first-page":"e12764","DOI":"10.1371\/journal.pone.0012764","article-title":"Schistosomiasis coinfection in children influences acquired immune response against Plasmodium falciparum malaria antigens","volume":"5","author":"Diallo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2013.10.014_bb0135","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1073\/pnas.0337629100","article-title":"The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria","volume":"100","author":"Makobongo","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cis.2013.10.014_bb0140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nature00937","article-title":"Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria","volume":"418","author":"Schofield","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cis.2013.10.014_bb0145","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.4049\/jimmunol.164.10.5005","article-title":"Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses","volume":"164","author":"Molano","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cis.2013.10.014_bb0150","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/515331","article-title":"Phase I\/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria","volume":"177","author":"Ockenhouse","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb0155","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS, S\/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial","volume":"366","author":"Alonso","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cis.2013.10.014_bb0160","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS, S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial","volume":"364","author":"Alonso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cis.2013.10.014_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neurol.2012.01.582","article-title":"Cerebral malaria: what is known and what is on research","volume":"168","author":"Gay","year":"2012","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.cis.2013.10.014_bb0170","first-page":"245","article-title":"Adjuvant therapy in cerebral malaria","volume":"124","author":"Mohanty","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0175","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.vaccine.2005.12.041","article-title":"A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS, S\/AS02A and MVA-CS","volume":"24","author":"Dunachie","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.cis.2013.10.014_bb0180","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/S0264-410X(01)00260-2","article-title":"A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees","volume":"19","author":"Schneider","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.cis.2013.10.014_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.1999.tb01326.x","article-title":"Induction of CD8+ T cells using heterologous prime-boost immunisation strategies","volume":"170","author":"Schneider","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cis.2013.10.014_bb0190","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1371\/journal.pmed.1000020","article-title":"Malaria control with transgenic mosquitoes","volume":"6","author":"Marshall","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.cis.2013.10.014_bb0195","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.1081453","article-title":"Impact of genetic manipulation on the fitness of Anopheles stephensi mosquitoes","volume":"299","author":"Catteruccia","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cis.2013.10.014_bb0200","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbrc.2003.08.027","article-title":"In vivo gene silencing in Plasmodium berghei\u2014a mouse malaria model","volume":"309","author":"Mohmmed","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cis.2013.10.014_bb0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0065-308X(08)60021-4","article-title":"The pathophysiology of malaria","volume":"31","author":"White","year":"1992","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0210","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0035-9203(99)90368-1","article-title":"Cognitive sequelae of severe malaria with impaired consciousness","volume":"93","author":"Holding","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0215","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2004.043893","article-title":"Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children","volume":"76","author":"Carter","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cis.2013.10.014_bb0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1475-2875-11-95","article-title":"History of malaria research and its contribution to the malaria control success in Suriname: a review","volume":"11","author":"Breeveld","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.cis.2013.10.014_bb0225","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1365-3156.2001.00819.x","article-title":"History and importance of antimalarial drug resistance","volume":"6","author":"D'Alessandro","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.cis.2013.10.014_bb0230","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0035-9203(94)90102-3","article-title":"Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand","volume":"88","author":"Pukrittayakamee","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bmc.2010.11.036","article-title":"Synthesis, antiprotozoal, antimicrobial, beta-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines)","volume":"19","author":"Kaur","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.cis.2013.10.014_bb0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1475-2875-6-121","article-title":"World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria","volume":"6","author":"Plowe","year":"2007","journal-title":"Malar J"},{"key":"10.1016\/j.cis.2013.10.014_bb0245","doi-asserted-by":"crossref","first-page":"16192","DOI":"10.1074\/jbc.273.26.16192","article-title":"The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin","volume":"273","author":"Bhisutthibhan","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cis.2013.10.014_bb0250","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1128\/AAC.05943-11","article-title":"Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins","volume":"56","author":"Cui","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2013.10.014_bb0255","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0020-7519(02)00194-7","article-title":"Artemisinin: mechanisms of action, resistance and toxicity","volume":"32","author":"Meshnick","year":"2002","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0260","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/expr.1993.1010","article-title":"Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria","volume":"76","author":"ter Kuile","year":"1993","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0265","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2012.04.010","article-title":"Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice","volume":"131","author":"Aditya","year":"2012","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0270","first-page":"539","article-title":"Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria","volume":"22","author":"Bunnag","year":"1991","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.cis.2013.10.014_bb0275","doi-asserted-by":"crossref","first-page":"e40244","DOI":"10.1371\/journal.pone.0040244","article-title":"Effect of early detection and treatment on malaria related maternal mortality on the north-Western border of Thailand 1986\u20132010","volume":"7","author":"McGready","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2013.10.014_bb0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.femsle.2005.09.035","article-title":"Antimalarial drug synergism and antagonism: mechanistic and clinical significance","volume":"253","author":"Bell","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.cis.2013.10.014_bb0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0035-9203(98)90749-0","article-title":"Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria","volume":"92","author":"Sabchareon","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0290","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4269\/ajtmh.2005.73.842","article-title":"Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand","volume":"73","author":"Heppner","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0295","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(94)92526-7","article-title":"Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum","volume":"343","author":"Kuschner","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cis.2013.10.014_bb0300","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.actatropica.2011.09.009","article-title":"Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda","volume":"121","author":"Zeile","year":"2012","journal-title":"Acta Trop"},{"key":"10.1016\/j.cis.2013.10.014_bb0305","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.bmc.2012.03.011","article-title":"Antiplasmodial activity of novel keto-enamine chalcone\u2013chloroquine based hybrid pharmacophores","volume":"20","author":"Sashidhara","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.cis.2013.10.014_bb0310","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00283-12","article-title":"Artemisinin-based combination therapy against P. vivax: Comparative ex vivo activity of next-generation endoperoxides in multidrug resistant field isolates","author":"Marfurt","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2013.10.014_bb0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpddr.2011.11.001","article-title":"Degrees of chloroquine resistance in Plasmodium \u2014 is the redox system involved?","volume":"2","author":"Lehane","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.cis.2013.10.014_bb0320","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/infdis\/jis418","article-title":"Identification of a new chemical class of antimalarials","volume":"206","author":"Brunner","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb0325","first-page":"494","article-title":"In vitro assessment of drug resistance in Plasmodium falciparum in five States of India","volume":"135","author":"Anvikar","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1708-8305.2012.00607.x","article-title":"A cluster of acute diarrhea suspected to be cholera in French travelers in Haiti, December 2010","volume":"19","author":"Rachel","year":"2012","journal-title":"J Travel Med"},{"key":"10.1016\/j.cis.2013.10.014_bb0335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1475-2875-11-91","article-title":"Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether\u2013lumefantrine","volume":"11","author":"Corpolongo","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.cis.2013.10.014_bb0340","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3855\/jidc.2177","article-title":"Plasmodium falciparum malaria, bilateral sixth cranial nerve palsy and delayed cerebellar ataxia","volume":"6","author":"Duque","year":"2012","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.cis.2013.10.014_bb0345","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00436-012-2851-8","article-title":"Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication?","volume":"111","author":"Franken","year":"2012","journal-title":"Parasitol Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0350","first-page":"1279","article-title":"Prophylactic use of antimalarials during pregnancy","volume":"57","author":"Irvine","year":"2011","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.cis.2013.10.014_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488606775252584","article-title":"Antimalarial drugs in pregnancy: a review","volume":"1","author":"Nosten","year":"2006","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.cis.2013.10.014_bb0360","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0365","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0035-9203(03)80041-X","article-title":"Case report: life-threatening hypoglycaemia associated with sulfadoxine\u2013pyrimethamine, a commonly used antimalarial drug","volume":"97","author":"Fairhurst","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0370","first-page":"14","article-title":"Synthesis and biological activity of new potential antimalarial: 1H-pyrazolo[3,4-b]pyridine derivatives","volume":"139","author":"Dias","year":"2000","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.cis.2013.10.014_bb0375","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4269\/ajtmh.1986.35.472","article-title":"Adaptation of the Indochina I\/CDC strain of Plasmodium falciparum to the squirrel monkey (Saimiri sciureus)","volume":"35","author":"Campbell","year":"1986","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl. 1","key":"10.1016\/j.cis.2013.10.014_bb0380","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00508-011-0044-6","article-title":"Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand","volume":"123","author":"Treiber","year":"2011","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.cis.2013.10.014_bb0385","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/jiq038","article-title":"Selective sweeps and genetic lineages of Plasmodium falciparum drug-resistant alleles in Ghana","volume":"203","author":"Alam","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb0390","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3201\/eid1405.071601","article-title":"Declining artesunate\u2013mefloquine efficacy against falciparum malaria on the Cambodia\u2013Thailand border","volume":"14","author":"Wongsrichanalai","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb0395","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1756-3305-5-154","article-title":"Severe Plasmodium vivax malaria among Sudanese children at New Halfa Hospital, Eastern Sudan","volume":"5","author":"Mahgoub","year":"2012","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.cis.2013.10.014_bb0400","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1258\/td.2012.120038","article-title":"Plasmodium vivax remains responsive to chloroquine with primaquine treatment regimen: a prospective cohort study from tertiary care teaching hospital in southern India","volume":"42","author":"Saravu","year":"2012","journal-title":"Trop Doct"},{"key":"10.1016\/j.cis.2013.10.014_bb0405","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1475-2875-10-368","article-title":"Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand","volume":"10","author":"Phompradit","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.cis.2013.10.014_bb0410","doi-asserted-by":"crossref","first-page":"e28357","DOI":"10.1371\/journal.pone.0028357","article-title":"Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2013.10.014_bb0415","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1413-8670(10)70084-2","article-title":"Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon","volume":"14","author":"Ramos Junior","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb0920","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0140-6736(90)90033-2","article-title":"Proguanil, chloroquine, and mouth ulcers","volume":"335","author":"Drysdale","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cis.2013.10.014_bb0925","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(86)90799-3","article-title":"Mouth ulceration associated with proguanil","volume":"1","author":"Daniels","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.cis.2013.10.014_bb0930","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1590\/S0037-86822011000500010","article-title":"Quality of essential drugs in tropical countries: evaluation of antimalarial drugs in the Brazilian Health System","volume":"44","author":"Nogueira","year":"2011","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.cis.2013.10.014_bb0935","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00007691-200112000-00003","article-title":"Drug monitoring of quinine in men with nonsevere falciparum malaria: study in the Amazon region of Brazil","volume":"23","author":"Vieira","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cis.2013.10.014_bb0940","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jemermed.2012.02.051","article-title":"A Case of Imported Severe Plasmodium falciparum Malaria in the Emergency Department and the Current Role of Exchange Transfusion Treatment","volume":"44","author":"Habeeb","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.cis.2013.10.014_bb0945","first-page":"293","article-title":"Transfusion-transmitted malaria in a kidney transplant recipient. How safe is our blood transfusion?","volume":"29","author":"Alkhunaizi","year":"2008","journal-title":"Saudi Med J"},{"key":"10.1016\/j.cis.2013.10.014_bb0950","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ajh.21018","article-title":"Malaria and hereditary elliptocytosis","volume":"83","author":"Boctor","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cis.2013.10.014_bb0955","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.410430603","article-title":"Neurological manifestations of falciparum malaria","volume":"43","author":"Newton","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cis.2013.10.014_bb0960","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/jm070149m","article-title":"Malaria-infected mice are cured by a single dose of novel artemisinin derivatives","volume":"50","author":"Posner","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2013.10.014_bb0965","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0020-7519(02)00195-9","article-title":"Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds","volume":"32","author":"Borstnik","year":"2002","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0970","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4269\/ajtmh.2012.12-0025","article-title":"Artemisinin-resistant malaria: research challenges, opportunities, and public health implications","volume":"87","author":"Fairhurst","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0975","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(97)00510-8","article-title":"An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials","volume":"55","author":"Dorn","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cis.2013.10.014_bb0980","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4269\/ajtmh.2000.62.573","article-title":"Assessment of the antimalarial potential of tetraoxane WR 148999","volume":"62","author":"Vennerstrom","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb0985","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1021\/jm0000766","article-title":"Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2]hexadecanes","volume":"43","author":"Vennerstrom","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2013.10.014_bb0990","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2125.1999.00044.x","article-title":"Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin","volume":"48","author":"Svensson","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cis.2013.10.014_bb0995","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb1000","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0035-9203(00)90082-8","article-title":"Artemether\u2013lumefantrine for the treatment of multidrug-resistant falciparum malaria","volume":"94","author":"van Vugt","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb1005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether\u2013lumefantrine","volume":"37","author":"White","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cis.2013.10.014_bb1010","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4269\/ajtmh.1998.58.638","article-title":"A randomized controlled trial of artemether\/benflumetol, a new antimalarial and pyrimethamine\/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children","volume":"58","author":"von Seidlein","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cis.2013.10.014_bb1015","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1021\/jm010131q","article-title":"Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum","volume":"45","author":"Tarnchompoo","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2013.10.014_bb1020","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2217\/fmb.10.136","article-title":"Antimalarial drugs: modes of action and mechanisms of parasite resistance","volume":"5","author":"Muller","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.cis.2013.10.014_bb1025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/092986707780090927","article-title":"Recent advances in antimalarial compounds and their patents","volume":"14","author":"Mital","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cis.2013.10.014_bb1030","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1568026023392986","article-title":"Chemotherapeutic agents against malaria: what next after chloroquine?","volume":"2","author":"Dominguez","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.cis.2013.10.014_bb1035","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1021\/jm1006462","article-title":"Design, synthesis, and development of novel guaianolide-endoperoxides as potential antimalarial agents","volume":"53","author":"Sun","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2013.10.014_bb1040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chemphyslip.2009.04.005","article-title":"Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid","volume":"160","author":"Kumura","year":"2009","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.cis.2013.10.014_bb0420","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbrc.2004.11.051","article-title":"Curcumin for malaria therapy","volume":"326","author":"Reddy","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cis.2013.10.014_bb0425","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/AAC.50.5.1859-1860.2006","article-title":"Curcumin\u2013artemisinin combination therapy for malaria","volume":"50","author":"Nandakumar","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2013.10.014_bb0430","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10408690490424702","article-title":"Biological properties of curcumin-cellular and molecular mechanisms of action","volume":"44","author":"Joe","year":"2004","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.cis.2013.10.014_bb0435","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med"},{"key":"10.1016\/j.cis.2013.10.014_bb0440","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1039\/b502142c","article-title":"Size matters: why nanomaterials are different","volume":"35","author":"Roduner","year":"2006","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cis.2013.10.014_bb0445","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2011.05.003","article-title":"Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid technology","volume":"414","author":"Steyn","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0450","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2011.01.050","article-title":"Evaluation of the physical properties and stability of two lipid drug delivery systems containing mefloquine","volume":"409","author":"Slabbert","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0455","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cis.2013.10.014_bb0460","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","article-title":"Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice","volume":"80","author":"Isacchi","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0465","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2011.01.001","article-title":"A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro","volume":"151","author":"Urban","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2013.10.014_bb0470","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/1556-276X-6-620","article-title":"Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors","volume":"6","author":"Urban","year":"2011","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.cis.2013.10.014_bb0475","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0731-7085(02)00678-7","article-title":"Physical and chemical evaluation of liposomes, containing artesunate","volume":"31","author":"Gabriels","year":"2003","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cis.2013.10.014_bb0480","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.exppara.2009.04.004","article-title":"Evaluation of Artemisia annua infusion efficacy for the treatment of malaria in Plasmodium chabaudi chabaudi infected mice","volume":"122","author":"Atemnkeng","year":"2009","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0731-7085(01)00611-2","article-title":"Preparation of beta-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice","volume":"28","author":"Chimanuka","year":"2002","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cis.2013.10.014_bb0490","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-5173(95)04273-3","article-title":"Evaluation of liposomal formulations containing the antimalarial agent arteether","volume":"128","author":"Al-Angary","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(98)00182-3","article-title":"In vivo evaluation of arteether liposomes","volume":"175","author":"Bayomi","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0500","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/AAC.39.1.180","article-title":"Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice","volume":"39","author":"Owais","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2013.10.014_bb0505","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0005-2736(89)90037-0","article-title":"Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ","volume":"981","author":"Peeters","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cis.2013.10.014_bb0510","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/A:1015927614920","article-title":"Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria","volume":"6","author":"Peeters","year":"1989","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0515","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-3659(90)90136-H","article-title":"Drug-laden liposomes in antitumor therapy and in the treatment of parasitic diseases","volume":"11","author":"Crommelin","year":"1990","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2013.10.014_bb0520","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0168-3659(91)90038-F","article-title":"Liposomes and immunoliposomes for controlled release or site specific delivery of antiparasitic drugs and cystostatics","volume":"16","author":"Crommelin","year":"1991","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2013.10.014_bb0525","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2008.05.010","article-title":"Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method","volume":"361","author":"Qiu","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0530","first-page":"114","article-title":"Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice","volume":"288","author":"Postma","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cis.2013.10.014_bb0535","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11095-006-9609-x","article-title":"Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence","volume":"23","author":"Longmuir","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0540","first-page":"261","article-title":"Ethnic differences in the reactions to drugs and xenobiotics. The metabolism and toxicity of primaquine","volume":"214","author":"Price","year":"1986","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0545","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-291X(87)91118-1","article-title":"Functional drug targeting to erythrocytes in vivo using antibody bearing liposomes as drug vehicles","volume":"148","author":"Agrawal","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cis.2013.10.014_bb0550","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-5173(00)00338-0","article-title":"Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design","volume":"198","author":"Stensrud","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0555","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/00034983.1983.11811725","article-title":"Studies on the kinetics of uptake and distribution of free and liposome-entrapped primaquine, and of sporozoites by isolated perfused rat liver","volume":"77","author":"Smith","year":"1983","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0560","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/0006-2952(82)90633-5","article-title":"The disposition of free and liposomally encapsulated antimalarial primaquine in mice","volume":"31","author":"Pirson","year":"1982","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cis.2013.10.014_bb0565","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/02652049509006778","article-title":"Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes","volume":"12","author":"Arica","year":"1995","journal-title":"J Microencapsul"},{"key":"10.1016\/j.cis.2013.10.014_bb0570","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10717540802006211","article-title":"Liposomal polyethyleneglycol and polyethyleneglycol\u2013peptide combinations for active targeting to liver in vivo","volume":"15","author":"Haynes","year":"2008","journal-title":"Drug Deliv"},{"key":"10.1016\/j.cis.2013.10.014_bb0575","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/expr.1998.4282","article-title":"Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria","volume":"89","author":"Postma","year":"1998","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0580","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.vaccine.2010.05.033","article-title":"The RTS,S malaria vaccine","volume":"28","author":"Casares","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cis.2013.10.014_bb0585","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/IAI.60.6.2438-2444.1992","article-title":"Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages","volume":"60","author":"Verma","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.cis.2013.10.014_bb0590","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2006.11.023","article-title":"Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB\/c mice","volume":"25","author":"Sharma","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.cis.2013.10.014_bb0595","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-5173(02)00639-7","article-title":"Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters","volume":"253","author":"Shahgaldian","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0600","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-3-642-00477-3_4","article-title":"Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes","author":"Souto","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.cis.2013.10.014_bb0605","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2013.10.014_bb0610","unstructured":"Muller RH, Lucks JS. Arzneistofftrager aus festen Lipidteilchen, Feste Lipidnanosph\u00e4ren (SLN). European Patent No EP 0605497. 1996."},{"key":"10.1016\/j.cis.2013.10.014_bb0615","unstructured":"Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. US Patent No 5250236. 1993."},{"key":"10.1016\/j.cis.2013.10.014_bb0620","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.colsurfb.2010.07.020","article-title":"Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment","volume":"81","author":"Nayak","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2013.10.014_bb0625","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.colsurfb.2010.07.020","article-title":"Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment","volume":"81","author":"Nayak","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2013.10.014_bb0630","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejps.2010.05.007","article-title":"Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activity","volume":"40","author":"Aditya","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.cis.2013.10.014_bb0635","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.powtec.2009.09.004","article-title":"Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology","volume":"197","author":"Zhang","year":"2010","journal-title":"Powder Technol"},{"key":"10.1016\/j.cis.2013.10.014_bb0640","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2008.07.032","article-title":"Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: nanoject","volume":"364","author":"Joshi","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0645","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1211\/jpp.59.7.0004","article-title":"Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain","volume":"59","author":"Gupta","year":"2007","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.cis.2013.10.014_bb0650","first-page":"1","article-title":"Lipid nanoemulsions for anticancer drug therapy","volume":"66","author":"Souto","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.cis.2013.10.014_bb0655","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2005.07.015","article-title":"Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy","volume":"303","author":"Dierling","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0660","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2007.06.035","article-title":"Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine","volume":"347","author":"Singh","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0665","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2008.06.012","article-title":"Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria","volume":"362","author":"Joshi","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0670","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-5173(96)04801-6","article-title":"Interactions between liposomes and chitosan II: effect of selected parameters on aggregation and leakage","volume":"146","author":"Henriksen","year":"1997","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0675","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","article-title":"Nanotechnology: intelligent design to treat complex disease","volume":"23","author":"Covreur","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DDC-120001481","article-title":"Nanoparticle technology for drug delivery across the blood\u2013brain barrier","volume":"28","author":"Lockman","year":"2002","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0685","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s000180300002","article-title":"Colloidal drug carriers: achievements and perspectives","volume":"60","author":"Barratt","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.cis.2013.10.014_bb0690","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1166\/jbn.2007.038","article-title":"Nanomedicines: a new approach for the treatment of serious diseases","volume":"3","author":"Vauthier","year":"2007","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.cis.2013.10.014_bb0695","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.msec.2006.05.029","article-title":"Modification of nanostructured materials for biomedical applications","volume":"27","author":"Xu","year":"2007","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.cis.2013.10.014_bb0700","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biotechadv.2011.05.009","article-title":"Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice","volume":"30","author":"Akhtar","year":"2012","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.cis.2013.10.014_bb0705","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1166\/jbn.2012.1366","article-title":"Preparation and characterization of monensin loaded PLGA nanoparticles: in vitro anti-malarial activity against Plasmodium falciparum","volume":"8","author":"Surolia","year":"2012","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.cis.2013.10.014_bb0710","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1002\/jps.22191","article-title":"Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation","volume":"99","author":"Dandekar","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.cis.2013.10.014_bb0715","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2006.03.034","article-title":"Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles","volume":"319","author":"Foger","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0720","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1517\/17425247.2012.716421","article-title":"Aptamer-dendrimer bioconjugate: a nanotool for therapeutics, diagnosis, and imaging","volume":"9","author":"Pednekar","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.cis.2013.10.014_bb0725","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s11095-012-0683-y","article-title":"Click chemistry with polymers, dendrimers, and hydrogels for drug delivery","volume":"29","author":"Lallana","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0730","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1773-2247(05)50008-X","article-title":"PEGylated peptide-based dendritic nanoparticulate systems for delivery of artemether","volume":"15","author":"Bhadra","year":"2005","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.cis.2013.10.014_bb0735","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11095-005-9396-9","article-title":"PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate","volume":"23","author":"Bhadra","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0740","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2005.01.026","article-title":"Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting","volume":"295","author":"Bhadra","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0745","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-8-39","article-title":"Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies","volume":"8","author":"Gomes","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cis.2013.10.014_bb0750","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1208\/s12249-010-9478-9","article-title":"Self-microemulsifiyng suppository formulation of beta-artemether","volume":"11","author":"Gugulothu","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.cis.2013.10.014_bb0755","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2008.06.021","article-title":"Development of SMEDDS using natural lipophile: application to beta-Artemether delivery","volume":"362","author":"Mandawgade","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0760","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2013.10.014_bb0765","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1081\/DDC-120025460","article-title":"Inclusion complexation of artemisinin with alpha-, beta-, and gamma-cyclodextrins","volume":"29","author":"Wong","year":"2003","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.cis.2013.10.014_bb0770","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bcp.2006.10.030","article-title":"Sulfated cyclodextrins inhibit the entry of Plasmodium into red blood cells. Implications for malarial therapy","volume":"73","author":"Crandall","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cis.2013.10.014_bb0775","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/jps.20106","article-title":"Nuclear magnetic resonance and molecular modeling analysis of the interaction of the antimalarial drugs artelinic acid and artesunic acid with beta-cyclodextrin","volume":"93","author":"Hartell","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.cis.2013.10.014_bb0780","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12272-009-1130-4","article-title":"Dihydroartemisinin\u2013cyclodextrin complexation: solubility and stability","volume":"32","author":"Ansari","year":"2009","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0785","first-page":"858","article-title":"Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems","volume":"62","author":"Onyeji","year":"2007","journal-title":"Pharmazie"},{"key":"10.1016\/j.cis.2013.10.014_bb0790","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1475-2875-10-118","article-title":"Quantum dots: a new tool for anti-malarial drug assays","volume":"10","author":"Ku","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.cis.2013.10.014_bb0795","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0928-0987(03)00147-7","article-title":"Introduction to micro-analytical systems: bioanalytical and pharmaceutical applications","volume":"20","author":"Huikko","year":"2003","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.cis.2013.10.014_bb0800","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.actatropica.2003.11.009","article-title":"Microfluidic approaches to malaria detection","volume":"89","author":"Gascoyne","year":"2004","journal-title":"Acta Trop"},{"key":"10.1016\/j.cis.2013.10.014_bb0805","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.actatropica.2011.03.003","article-title":"Larvicidal activity of synthesized silver nanoparticles using Eclipta prostrata leaf extract against filariasis and malaria vectors","volume":"118","author":"Rajakumar","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.cis.2013.10.014_bb0810","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00436-010-2115-4","article-title":"Synthesis of silver nanoparticles using Nelumbo nucifera leaf extract and its larvicidal activity against malaria and filariasis vectors","volume":"108","author":"Santhoshkumar","year":"2011","journal-title":"Parasitol Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0815","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","article-title":"Malaria: progress, perils, and prospects for eradication","volume":"118","author":"Greenwood","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cis.2013.10.014_bb0820","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2008.07.004","article-title":"Artemisinins: their growing importance in medicine","volume":"29","author":"Krishna","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cis.2013.10.014_bb0825","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pt.2005.05.013","article-title":"Malaria parasite transporters as a drug-delivery strategy","volume":"21","author":"Biagini","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0830","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0166-6851(92)90253-G","article-title":"The movement of fluorescent endocytic tracers in Plasmodium falciparum infected erythrocytes","volume":"50","author":"Haldar","year":"1992","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0835","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0166-6851(94)90038-8","article-title":"Characterization of trafficking pathways and membrane genesis in malaria-infected erythrocytes","volume":"66","author":"Pouvelle","year":"1994","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0840","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02628503","article-title":"falciparum infected erythrocytes are capable of endocytosis","volume":"24","author":"Burns","year":"1988","journal-title":"In Vitro Cell Dev Biol"},{"key":"10.1016\/j.cis.2013.10.014_bb0845","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1083\/jcb.80.2.481","article-title":"Domains of receptor mobility and endocytosis in the membranes of neonatal human erythrocytes and reticulocytes are deficient in spectrin","volume":"80","author":"Tokuyasu","year":"1979","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cis.2013.10.014_bb0850","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0166-6851(84)90134-8","article-title":"The biosynthesis of the knob protein and a 65 000dalton histidine-rich polypeptide of Plasmodium falciparum","volume":"12","author":"Kilejian","year":"1984","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0855","first-page":"83","article-title":"Alteration in membrane proteins of mouse erythrocytes infected with different species and strains of malaria parasites","volume":"63B","author":"Yuthavong","year":"1979","journal-title":"Comp Biochem Physiol"},{"key":"10.1016\/j.cis.2013.10.014_bb0860","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1021\/es0522635","article-title":"Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques","volume":"40","author":"Rothen-Rutishauser","year":"2006","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.cis.2013.10.014_bb0865","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-6851(97)00039-X","article-title":"Characterization of macromolecular transport pathways in malaria-infected erythrocytes","volume":"87","author":"Goodyer","year":"1997","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.cis.2013.10.014_bb0870","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.276.5315.1122","article-title":"A membrane network for nutrient import in red cells infected with the malaria parasite","volume":"276","author":"Lauer","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cis.2013.10.014_bb0875","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0169-4758(97)01077-6","article-title":"Presence of the parasitophorous duct in Plasmodium falciparum and P. vivax parasitized Saimiri monkey red blood cells","volume":"13","author":"Pouvelle","year":"1997","journal-title":"Parasitol Today"},{"key":"10.1016\/j.cis.2013.10.014_bb0880","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/353073a0","article-title":"Direct access to serum macromolecules by intraerythrocytic malaria parasites","volume":"353","author":"Pouvelle","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.cis.2013.10.014_bb0885","first-page":"708","article-title":"The initiation of a \u201cmetabolic window\u201d in the surface of host erythrocytes by Plasmodium berghei NYU-2","volume":"28","author":"Bodammer","year":"1973","journal-title":"Lab Invest"},{"key":"10.1016\/j.cis.2013.10.014_bb0890","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00436-001-0537-8","article-title":"Traffic pathways of Plasmodium vivax antigens during intraerythrocytic parasite development","volume":"88","author":"Bracho","year":"2002","journal-title":"Parasitol Res"},{"key":"10.1016\/j.cis.2013.10.014_bb0895","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1078\/0171-9335-00319","article-title":"Evidence for trafficking of PfEMP1 to the surface of P. falciparum-infected erythrocytes via a complex membrane network","volume":"82","author":"Wickert","year":"2003","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.cis.2013.10.014_bb0900","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/AAC.36.5.1102","article-title":"Effects of cinnamic acid derivatives on in vitro growth of Plasmodium falciparum and on the permeability of the membrane of malaria-infected erythrocytes","volume":"36","author":"Kanaani","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2013.10.014_bb0905","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0005-2736(95)00055-8","article-title":"Parasite-induced permeation of nucleosides in Plasmodium falciparum malaria","volume":"1236","author":"Upston","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cis.2013.10.014_bb0910","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01116501","article-title":"New permeability pathways induced by the malarial parasite in the membrane of its host erythrocyte: potential routes for targeting of drugs into infected cells","volume":"7","author":"Ginsburg","year":"1987","journal-title":"Biosci Rep"},{"key":"10.1016\/j.cis.2013.10.014_bb0915","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.2001.81.2.495","article-title":"Membrane transport in the malaria-infected erythrocyte","volume":"81","author":"Kirk","year":"2001","journal-title":"Physiol Rev"}],"container-title":["Advances in Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868613001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868613001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T05:37:50Z","timestamp":1596692270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001868613001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":208,"alternative-id":["S0001868613001292"],"URL":"https:\/\/doi.org\/10.1016\/j.cis.2013.10.014","relation":{},"ISSN":["0001-8686"],"issn-type":[{"value":"0001-8686","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in nanomedicines for malaria treatment","name":"articletitle","label":"Article Title"},{"value":"Advances in Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cis.2013.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}